Tissue inhibitor of metallopeptidase 1 (TIMP1), an X encoded protein required for normal extracellular matrix remodelling is elevated in pulmonary blood vessels in the plasma of patients with PAH and is a predictor of poor prognosis. This evidence concerns the gene TIMP1 and pulmonary arterial hypertension.